GLRX and early-onset autosomal dominant Alzheimer disease: GLRX has been associated with autism, cognitive aging in healthy people and amyloid‐β neuropathology in Alzheimer's disease (Bowers et al., 2011; Harris et al., 2007; Wang et al., 2020).